Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35101358)
Watch
English
A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
title
A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
main subject
angiogenesis inhibitor
1 reference
based on heuristic
inferred from title
metastatic breast cancer
1 reference
based on heuristic
inferred from title
author
Eric Guerin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
author name string
Shan Man
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
Ping Xu
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
Robert S Kerbel
series ordinal
4
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
language of work or name
English
0 references
publication date
22 April 2013
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
published in
Cancer Research
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
volume
73
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
issue
9
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
page(s)
2743-2748
1 reference
stated in
Europe PubMed Central
PMC publication ID
4334448
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23610448%20AND%20SRC:MED&resulttype=core&format=json
retrieved
29 February 2020
cites work
An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Controlling angiogenesis in breast cancer: a systematic review of anti-angiogenic trials
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Mouse models of advanced spontaneous metastasis for experimental therapeutics
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
In the end what matters most? A review of clinical endpoints in advanced breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Murine models to evaluate novel and conventional therapeutic strategies for cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Practices and pitfalls of mouse cancer models in drug discovery.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
The mighty mouse: genetically engineered mouse models in cancer drug development
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
What's wrong with our cancer models?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
9 July 2018
First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: results of a prospective, randomized phase III study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
27 September 2018
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
27 September 2018
Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
27 September 2018
Vessel co-option: how tumors obtain blood supply in the absence of sprouting angiogenesis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4334448
retrieved
27 September 2018
Dynamic stromal-epithelial interactions during progression of MCF10DCIS.com xenografts
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/23610448
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1158/0008-5472.CAN-12-4183
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/hjuadht3nndx3e4d3b6spvbwse
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
Fatcat ID
release_hjuadht3nndx3e4d3b6spvbwse
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/hjuadht3nndx3e4d3b6spvbwse
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
PMC publication ID
4334448
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/hjuadht3nndx3e4d3b6spvbwse
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
PubMed publication ID
23610448
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/hjuadht3nndx3e4d3b6spvbwse
retrieved
30 July 2022
based on heuristic
mapped directly with Wikidata item
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit